Ivermectin in mild and moderate COVID-19 (RIVET-COV): a randomized, placebo-controlled trial
Research Square Platform LLC (2021) - Comments
doi: 10.21203/rs.3.rs-191648/v1 

Anant Mohan, Pawan Tiwari, Tejas Suri, Saurabh Mittal, Ankit Patel, Avinash Jain, Velpandian T., Ujjwal Kumar Das, Tarun K. Bopanna, RM Pandey, Sushil Shelke, Angel Rajan Singh, Sushma Bhatnagar, Shet Masih, Shelly Mahajan, Tanima Dwivedi, Biswajeet Sahoo, Anuja Pandit, Shweta Bhopale, Saurabh Vig